← Eichor
Study identifier: NCT06895252 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Condition: Ulcerative Colitis (UC)  ·  Sponsor: All India Institute of Medical Sciences

PhaseNA
Planned participants220
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon and rectum, characterized by mucosal inflammation and symptomslike diarrhea, abdominal pain, and rectal bleeding. It is a subtype of inflammatory bowel disease (IBD) and results from a combination of genetic predisposition, environmental factors, and immune dysregulation. UC is associated with significant gut microbiota dysbiosis, marked by reduced beneficial bacteria and increased harmful taxa. With rising prevalence in developing countries like India, effective and accessible treatments remain a critical need. This multi-center randomized factorial double blind placebo controlled treat through trial will utilize a 2x 2 factorial design to randomize patients of mild to moderate (modified Mayo score 3-6) endoscopically active (Mayo endoscopic score: \>1) treatment naÃive UC in 1:1:1:1 ratio to fecal microbiota transplantation (FMT) + anti-inflammatory diet (AID) +5-aminisalicylic acid (5-ASA) (Intervention, Group A) vs fecal microbiota transplantation + sham diet +5-aminisalicylic acid(Intervention, Group B) vs sham transplantation + anti-inflammatory diet +5-aminisalicylic acid(Intervention, Group C) vs sham transplantation \+ sham diet +5-aminisalicylic acid(Control, Group D). In the induction phase patients will receive FMT/sham transplantation at 0, 2 and 6 weeks along with AID/Sham diet and 5-ASA for 10 weeks. Outcome will be assessed at 10 weeks, Treatment failure will be out of trial. Pati…

This description comes directly from the study's public registry record.

Talk to the study team

Prof Vineet Ahuja, DM Gastroenterology  ·  +91-9810707170  ·  vineet.aiims@gmail.com

Dr Himanshu Narang, DM Gastroenterology  ·  +91-8800316504  ·  h92narang@gmail.com

Always discuss trial participation with your own doctor first.

Locations (6)

Department of Gastroenterology, Lisie HospitalKochi, Kerala, IndiaNot Yet Recruiting
Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College, SionMumbai, Maharashtra, IndiaNot Yet Recruiting
Department of Gastroenterology and Human Nutrition, All India Institute of Medical SciencesNew Delhi, National Capital Territory of Delhi, IndiaRecruiting
Department of Gastroenterology, Dayanand Medical CollegeLudhiana, Punjab, IndiaNot Yet Recruiting
Department of Gastroentrology, Postgraduate Institute of Medical Education and ResearchChandigarh, Punjab/Haryana, IndiaNot Yet Recruiting
Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu UniversityVaranasi, Uttar Pradesh, IndiaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06895252